Monoclonal Antibodies for Therapeutic Use: Specific Characteristics of Clinical Development, Evaluation by the Agencies, and Long-term Monitoring of Safety
Gilles Paintaud, Marine Diviné, Philippe Lechat et participants of Round Table N°5 of Giens XXVII
